In the midst of the biggest financial crisis in a generation, a tiny biotech company, called Gene Network Sciences, of Cambridge, Mass., thinks it can make Wall Street smarter. How? Get rid of the humans. Their idea: Take the supercomputers Gene Network Sciences already uses to help Pfizer and Biogen Idec invent drugs and use them to help hedge funds trade stocks, bonds,and other assets.
Man Vs. Machine On Wall Street
November 24, 2008